A P Musliyar exhorts religious leaders of Dakshina Kannada to promote peace

Mangaluru, Jun 23: The wholesale fresh fish dealers have voluntarily decided to suspend sale for 10 days from June 24 in the wake of fresh coronavirus outbreak in the region. 

Convening the collective decision of the traders in a letter, K Ashraf, working president of the association of Mangaluru fisheries harbour fish traders and commission agents, has urged the deputy commissioner to formally impose ban on fish trade in the city for next 10 days to prevent the spread of the covid-19. 

Mr Ashraf stated that decision was taken as many fish traders suffering from symptoms such as cough, cold and fever for last few days and some of the traders have got themselves admitted in hospitals for treatment. 

The letter urged the DC to prevent and ban unauthorized traders selling fish not only in Bander but also in neighbourhoods like Ullal Kotepur, Hoige Bazar, Bengre, Farangipet, near VRL, Kudroli, Kallapu and Maripalla. 
 

Mangalore, Jan 12: Thieves reportedly stole around 70,000 cash from a MESCOM ATP machine located at Chembugudde in Thokkottu, Police said here on Sunday.

Police said that the theft took place in the MESCOM sub-division office at Chembugudde. It was said that the thieves broke open the room where the MESCOM customers bill payment machine was located and stole 70,000 rupees cash from the ATP machine.

This machine had nine lakh rupees cash. The amount was reported to have been transferred at around 1500 hrs on Saturday.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.